Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.5 |
mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.5 |
mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |